Search Results - "ЭЛЕКТРОСУДОРОЖНАЯ ТЕРАПИЯ"

Contributors: Авторы выражают глубокую признательность Александру Ильичу Нельсону за неоценимую помощь, критические замечания и советы, высказанные им в процессе подготовки авторами данной статьи.

Source: Acta Biomedica Scientifica; Том 5, № 2 (2020); 55-82 ; 2587-9596 ; 2541-9420

Subject Terms: электросудорожная терапия, extrapyramidal syndrome, neuroleptic-induced deficit syndrome, akathisia, drug-induced parkinsonism, cognitive impairment, electroconvulsive therapy, экстрапирамидный синдром, нейролептик-индуцированный дефицитарный синдром, акатизия, лекарственный паркинсонизм, когнитивные нарушения

File Description: application/pdf

Relation: https://www.actabiomedica.ru/jour/article/view/2300/2022; Kadiyala PK, Kadiyala LD. Anaesthesia for electroconvulsive therapy: An overview with an update on its role in potentiating electroconvulsive therapy. Indian J Anaesth. 2017; 61(5): 373-380. doi:10.4103/ija.IJA_132_17; Sundsted KK, Burton MC, Shah R, Lapid MI. Preanesthesia medical evaluation for electroconvulsive therapy: a review of the literature. J ECT. 2014; 30: 35-42. doi:10.1097/YCT.0b013e3182a3546f; Bartolommei N, Lattanzi L, Callari A, Cosentino L, Luchini F, Mauri M. Catatonia: a critical review and therapeutic recommendations. Journal of Psychopathology. 2012; 18: 234-246.; Hoirisch-Clapauch S, Mezzasalma MA, Nardi AE. Pivotal role of tissue plasminogen activator in the mechanism of action of electroconvulsive therapy. J Psychopharmacol. 2014; 28(2): 99105. doi:10.1177/0269881113507639; Medda P, Toni C, Perugi G. The mood-stabilizing effects of electroconvulsive therapy. J ECT. 2014; 30: 275-282. doi:10.1097/YCT.0000000000000160; Lambrecq V, Villega F, Marchal C, Michel V, Guehl D, Rotge JY, Burbaud P. Refractory status epilepticus: electroconvulsive therapy as a possible therapeutic strategy. Seizure. 2012; 21(9): 661-664. doi:10.1016/j.seizure.2012.07.010; Марыныч И.Н., Быков Ю.В, Нежинский Б.В. Использование электросудорожной терапии для коррекции аффективных расстройств у больных алкоголизмом с целью стабилизации ремиссии. [Электронный ресурс]. URL: https://psychoreanimatology.org/modules/articles/article.php?id=43; Марыныч И.Н., Быков Ю.В., Нежинский Б.В. Применение электросудорожной и атропинокоматозной терапии в комплексном лечении тяжёлых форм алкогольной зависимости. [Электронный ресурс]. URL: https://psychoreanimatology.org/modules/articles/article.php?id=51; Марыныч И.Н., Быков Ю.В., Нежинский Б.В. Терапевтическая эффективность электросудорожной терапии в раннем постабстинентном периоде у больных алкоголизмом. [Электронный ресурс]. URL: https://psychoreanimatology.org/modules/articles/article.php?id=44; Tharyan P, Adams CE. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev. 2005; 2: CD000076. doi:10.1002/14651858.CD000076.pub2; Singh A, Kar SK. How electroconvulsive therapy works?: Understanding the neurobiological mechanisms. Clin Psychopharmacol Neurosci. 2017; 15(3): 210-221. doi:10.9758/cpn.2017.15.3.210; Нельсон А.И. Электросудорожная терапия в психиатрии, наркологии и неврологии. М.: БИНОМ. Лаборатория знаний; 2005.; Malhotra AK, Litman RE, Pickar D. Adverse effects of antipsychotic drugs. Drug Saf. 1993; 9(6): 429-436. doi:10.2165/00002018-199309060-00005; Saltz BL, Robinson DG, Woerner MG. Recognizing and managing antipsychotic drug treatment side effects in the elderly. Prim Care Companion. J Clin Psychiatry. 2004; 6(Suppl 2): 14-19.; Carlson HE, Correll CU. Adverse effects of antipsychotics and mood stabilizers. Psychiatric times. 2007; 25(1). URL: https://www.psychiatrictimes.com/adverse-effects-antipsychotics-and-mood-stabilizers; Morrison P, Meehan T, Stomski NJ. Australian case managers> perceptions of mental health consumers use of antipsychotic medications and associated side-effects. Int J Ment Health Nurs. 2015; 24(2): 104-111. doi:10.1111/inm.12118; McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, et al. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res. 2005; 80(1): 19-32. doi:10.1016/j.schres.2005.07.014; Miranda PJ, DeFronzo RA, Califf RM, Guyton JR. Metabolic syndrome: definition, pathophysiology, and mechanisms. Am Heart J. 2005; 149(1): 33-45. doi:10.1016/j.ahj.2004.07.013; Stomski NJ, Morrison P, Meyer A. Antipsychotic medication side effect assessment tools: A systematic review. Aust N Z J Psychiatry. 2016; 50(5): 399-409. doi:10.1177/0004867415608244; Lader M. Some adverse effects of antipsychotics: Prevention and treatment: Current concepts and future prospects. J Clin Psychiatry Suppl. 1999; 60(S12): S18-S21.; Ascher-Svanum H, Zhu B, Faries DE, Lacro JP, Dolder CR, Peng X. Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia. Patient Prefer Adherence. 2008; 2: 67-77. doi:10.2147/ppa.s2940; Chapman SC, Horne R. Medication nonadherence and psychiatry. Curr Opin Psychiatry. 2013; 26(5): 446-452. doi:10.1097/YCO.0b013e3283642da4; Carlini ELDA, Nappo SA. The pharmacovigilance of psychoactive medications in Brazil. Braz J Psychiatry. 2003; 25(4): 200-205. doi:10.1590/s1516-44462003000400004; Hamer S, Haddad PM. Adverse effects of antipsychotics as outcome measures. Br J Psychiatry Suppl. 2007; 191(S50): s64-s70. doi:10.1192/bjp.191.50.s64; Stahl SM. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 4th edition. Cambridge, United Kingdom: Cambridge University Press; 2013.; Stahl SM. Stahl's Essential Psychopharmacology: Case studies. Volume 2. Cambridge, United Kingdom: Cambridge university press; 2015.; Stahl SM. Stahl's Essential Psychopharmacology: Prescriber's Guide. Cambridge, United Kingdom: Cambridge University Press; 2017.; Mukherjee S, Debsikdar V. Absence of neuroleptic-induced parkinsonism in psychotic patients receiving adjunctive electroconvulsive therapy. Convuls Ther. 1994; 10(1): 53-58.; Factor SA, Molho ES, Brown DL. Combined clozapine and electroconvulsive therapy for the treatment of drug-induced psychosis in Parkinson>s disease. J Neuropsychiatry Clin Neurosci. 1995; 7(3): 304-307. doi:10.1176/jnp.7.3.304; Vela L, Jimenez Moron D, Sanchez C, Pareja JA, Baron M. Camptocormia induced by atypical antipsychotics and resolved by electroconvulsive therapy. Mov Disord. 2006; 21(11): 1977-1980. doi:10.1002/mds.21101; Baez MA, Avery J. Improvement in drug-induced parkinsonism with electroconvulsive therapy. Am J Geriatr Pharmacother. 2011; 9(3): 190-193. doi:10.1016/j.amjopharm.2011.04.005; Беккер Р.А., Быков Ю.В. Акатизия: клинический анализ патологии с рекомендациями и обзором литературы. [Электронный ресурс]. URL: https://con-med.ru/upload/iblock/eaa/psi_akatisia2.pdf; Hermesh H, Aizenberg D, Friedberg G, Lapidot M, Munitz H. Electroconvulsive therapy for persistent neuroleptic-induced akathisia and parkinsonism: A case report. Biol Psychiatry. 1992; 31(4): 407-411. doi:10.1016/0006-3223(92)90235-r; Caspi N, Levine J. Treatment of resistant akathisia with ECT: a case report. Isr J Psychiatry Relat Sci. 1993; 30(3): 175-178.; Van Harten PN, Kahn RS. Tardive dystonia. Schizophrenia Bull. 1999; 25(4): 741-748. doi:10.1093/oxfordjournals.schbul.a033415; Havaki-Kontaxaki BJ, Kontaxakis VP, Margariti MM, Paplos KG, Christodoulou GN. Treatment of severe neuroleptic-induced tardive torticollis. Ann Gen Hosp Psychiatry. 2003; 2(1): 9. doi:10.1186/1475-2832-2-9; Besson JAO, Palin AN. Tardive dyskinesia, depression and ECT. Br J Psychiatry. 1991; 159(3): 446. doi:10.1192/bjp.159.3.446a; Gupta S, Mosnik D, Black DW, Berry S, Masand PS. Tardive dyskinesia: review of treatments past, present, and future. Ann Clin Psychiatry. 1999; 11(4): 257-266. doi:10.1023/a:1022369614773; Kennedy R, Mittal D, O>Jile J. Electroconvulsive therapy in movement disorders: an update. J Neuropsychiatry Clin Neurosci. 2003; 15(4): 407-421. doi:10.1176/jnp.15.4.407; Byne W, White L, Parella M, Adams R, Harvey PD, Davis KL. Tardive dyskinesia in a chronically institutionalized population of elderly schizophrenic patients: prevalence and association with cognitive impairment. Int J Geriatr Psychiatry. 1998; 13(7): 473-479. doi:10.1002/(sici)1099-1166(199807)13:73.0.co;2-z; Woerner MG, Alvir JMJ, Saltz BL, Lieberman JA, Kane JM. Prospective study of tardive dyskinesia in the elderly: rates and risk factors. Am J Psychiatry. 1998; 155(11): 1521-1528. doi:10.1176/ajp.155.11.1521; Yasui-Furukori N, Kikuchi A, Katagai H, Kaneko S. The effects of electroconvulsive therapy on tardive dystonia or dyskinesia induced by psychotropic medication: a retrospective study. Neuro-psychiatr Dis Treat. 2014; 10: 1209-1212. doi:10.2147/NDT.S62490.; Chacko RC, Root L. ECT and tardive dyskinesia: two cases and a review. J Clin Psychiatry. 1983; 44(7): 265-266.; Gosek E, Weller R. Improvement of tardive dyskinesia associated with electroconvulsive therapy. J Nerv Ment Dis. 1988; 176(2): 120-122. doi:10.1097/00005053-198802000-00009; Malek-Ahmadi P, Weddige R. Tardive dyskinesia and electroconvulsive therapy. Convuls Ther. 1988; 4(4): 328-331.; Roth SD, Mukherjee S, Sackeim HA. Electroconvulsive therapy in a patient with mania, parkinsonism, and tardive dyskinesia. Convuls Ther. 1988; 4(1): 92-97.; Hay DP, Hay L, Blackwell B, Spiro HR. ECT and tardive dyskinesia. J Geriatr Psychiatry Neurol. 1990; 3(2): 106-109. doi:10.1177/089198879000300209; Sandyk R. The relationship between ECT responsiveness and subtypes of tardive dyskinesia in bipolar patients. Int J Neurosci. 1990; 54(3-4): 315-319. doi:10.3109/00207459008986650; Hanin B, Lerner Y, Srour N. An unusual effect of ECT on drug-induced parkinsonism and tardive dystonia. Convuls Ther. 1995; 11(4): 271-274.; Ufok A, Ufok G. Maintenance ECT in a patient with catatonic schizophrenia and tardive dyskinesia. Convuls Ther. 1996; 12(2): 108-112.; Nobuhara K, Matsuda S, Okugawa G, Tamagaki C, Kinoshita T. Successful electroconvulsive treatment of depression associated with a marked reduction in the symptoms of tardive dyskinesia. J ECT. 2004; 20(4): 262-263. doi:10.1097/00124509200412000-00014; Sienaert P, Peuskens J. Remission of tardive dystonia (blepharospasm) after electroconvulsive therapy in a patient with treatment-refractory schizophrenia. J ECT. 2005; 21(2): 132-134. doi:10.1097/01.yct.0000167464.79327.0d; Sharma A, Hammer S, Egbert M, Sorrell JH. Electroconvulsive therapy and ocular dystonia. J ECT. 2007; 23(3): 181-182. doi:10.1097/YCT.0b013e31806548e4; Delay J, Pichot P, Lemperiere T, Elissalde B, Peigne F. A non-phenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses. Ann Med Psychol. 1960; 118(1): 145-152.; Беккер РА, Быков ЮВ, Морозов ПВ. Выдающиеся психиатры ХХ века. М.: ИД «Городец»; 2019.; Ruiz P. Addressing co-occurring disorders. Focus (Am Psychiatr Publ). 2017; 15(4): 9s-10s. doi:10.1176/appi.focus.154S11; Wysokinski A. Intensive electroconvulsive therapy in drug resistant neuroleptic malignant syndrome - case report. Psychiatr Danub. 2012; 24(2): 219-222.; Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry. 2007; 164 (6): 870-876. doi:10.1176/ajp.2007.164.6.870; Caroff SN, Mann SC, Campbell EC. Atypical antipsychotics and neuroleptic malignant syndrome. Psychiatric Annals. 2000; 30(5): 314-321. doi:10.3928/0048-5713-20000501-09; Caroff SN, Mann SC. Neuroleptic malignant syndrome. Psychopharmacol Bull. 1988; 24(1): 25-29.; Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am. 1993; 77(1): 185-202. doi:10.1016/s0025-7125(16)30278-4; Stubner S, Rustenbeck E, Grohmann R, Wagner G, Engel R, Neundorfer G, et al. Severe and uncommon involuntary movement disorders due to psychotropic drugs. Pharmacopsychiatry. 2004; 37(Suppl 1): S54-64. doi:10.1055/s-2004-815511; Caroff SN, Mann SC, Lazarus A. Neuroleptic malignant syndrome. Arch Gen Psychiatry. 1987; 44(9): 838-840. doi:10.1001/archpsyc.1987.01800210090015; Harland CC, O>Leary MM, Winters R, Owens J, Hayes B, Melikian V. Neuroleptic malignant syndrome: a case for electroconvulsive therapy. Postgrad Med J. 1990; 66(771): 49-51. doi:10.1136/pgmj.66.771.49; Verwiel JM, Verwey B, Heinis C, Thies JE, Bosch FH. Successful electroconvulsive therapy in a pregnant woman with neuroleptic malignant syndrome. Ned Tijdschr Geneeskd. 1994; 138(4): 196-199.; McKinney P, Kellner C. Multiple ECT late in the course of neuroleptic malignant syndrome. Convuls Ther. 1997; 13(4): 269-273.; Trollor JN, Sachdev PS. Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases. Aust N Z J Psychiatry. 1999; 33(5): 650-659. doi:10.1080/j.1440-1614.1999.00630.x; Nisijima K, Ishiguro T. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases. J ECT. 1999; 15(2): 158-163.; Kucia K, Warchala A. The application of electroconvulsive therapy in neuroleptic malignant syndrome treatment in a patient with catatonic schizophrenia. Wiad Lek. 2005; 58(9-10): 572-574.; Pandya HN, Keyes MJ, Christenson BC. Electroconvulsive therapy in a schizophrenic patient with neuroleptic malignant syndrome and pulmonary embolism: a case report. Psychiatry (Edgmont). 2007; 4(4): 21.; Patel AL, Shaikh WA, Khobragade AK, Soni HG, Joshi AS, Sahastrabuddhe GS. Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome. J Assoc Physicians India. 2008; 56: 49-50.; San Gabriel MC, Eddula-Changala B, Tan Y, Longshore CT. Electroconvulsive in a schizophrenic patient with neuroleptic malignant syndrome and rhabdomyolysis. J ECT. 2015; 31(3): 197-200. doi:10.1097/YCT.0000000000000184; Foguet-Boreu Q, Coll-Negre M, Serra-Millas M, Cavalleria-Verdaguer M. Neuroleptic malignant syndrome: a case responding to electroconvulsive therapy plus bupropion. Clin Pract. 2018; 8(1): 1044. doi:10.4081/cp.2018.1044; Hill SK, Bishop JR, Palumbo D, Sweeney JA. Effect of second-generation antipsychotics on cognition: current issues and future challenges. Expert Rev Neurother. 2010; 10(1): 43-57. doi:10.1586/ern.09.143; Biedermann F, Pfaffenberger N, Baumgartner S, Kem-mler G, Fleischhacker WW, Hofer A. Combined clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia: clinical and cognitive outcomes. J ECT. 2011; 27(4): e61-e62. doi:10.1097/YCT.0b013e31821a8f05; Rayikanti R, Lentowicz I, Birur B, Li L. Combined antipsychotics and electroconvulsive therapy in an acutely psychotic patient with treatment-resistant schizophrenia. Psychopharmacol Bull. 2017; 47(2): 57-62.; Pawetczyk A, Kotodziej-Kowalska E, Pawetczyk T, Rabe-Jabtonska J. Is there a decline in cognitive functions after combined electroconvulsive therapy and antipsychotic therapy in treatmentrefractory schizophrenia? J Nerv Ment Dis. 2015; 203(3): 182-186. doi:10.1097/NMD.0000000000000259; Vuksan Cusa B, Klepac N, Jaksic N, Bradas Z, Bozicevic M, Palac N, et al. The effects of electroconvulsive therapy augmentation of antipsychotic treatment on cognitive functions in patients with treatment-resistant schizophrenia. J ECT. 2018; 34(1): 31-34. doi:10.1097/YCT.0000000000000463; Buckley NA, Sanders P. Cardiovascular adverse effects of antipsychotic drugs. Drug Saf. 2000; 23(3): 215-228. doi:10.2165/00002018-200023030-00004; Nahshoni E, Manor N, Bar F, Stryjer R, Zalsman G, Weiz-man A. Alterations in QT dispersion in medicated schizophrenia patients following electroconvulsive therapy. Eur Neuropsychophar-macol. 2004; 14(2): 121-125. doi:10.1016/S0924-977X(03)00098-1; Gambhir S, Sandersfeld N, D'Mello D. A case of severe, refractory antipsychotic-induced orthostatic hypotension. Medical Student Research Journal. 2014; 4(Fall): 15-17. doi:10.3402/msrj.v3i0.201337; https://www.actabiomedica.ru/jour/article/view/2300

Availability: https://www.actabiomedica.ru/jour/article/view/2300
https://doi.org/10.29413/ABS.2020-5.2.9

View record from BASE

11

Academic Journal

CAN MELATONIN BE EFFECTIVELY USED TO DIMINISH SIDE EFFECTS OF VARIOUS PSYCHOTROPIC DRUGS AND ELECTROCONVULSIVE THERAPY?

Authors: Roman Aleksandrovich Bekker, Angelina Nailevna Hannanova, Yuriy Vitalevich Bykov

Source: В мире научных открытий, Vol 9, Iss 4, Pp 174-204 (2017)

Subject Terms: мелатонин, лекарственная инсомния, поздние дискинезии, акатизия, метаболический синдром, антипсихотики, антидепрессанты, электросудорожная терапия, побочные эффекты, эпифиз, Agriculture, Science

File Description: electronic resource

Relation: http://journal-s.org/index.php/vmno/article/view/10207; https://doaj.org/toc/2072-0831; https://doaj.org/toc/2307-9428

Access URL: https://doaj.org/article/ee68d5fc41064b5ca76a1630da46568b

View record in DOAJ Full Text Finder

12

Academic Journal

Злокачественный нейролептический синдром у больной биполярным аффективным расстройством на фоне лечения оланзапином

Authors: Малин, Д., Цукарзи, Э., Потапов, В., Манасевич, Г., Масленников, В.

Source: Современная терапия психических расстройств, Vol 2017, Iss 3 (42), Pp 27-32 (2017)

Subject Terms: биполярное аффективное расстройство, злокачественный нейролептический синдром, аутоиммунный nmdam рецепторный энцефалит, электросудорожная терапия, плазмаферез, инфузионная терапия, bipolar disorder, neuroleptic malignant syndrome, autoimmune nmdam receptor encephalitis, electroconvulsive therapy, plasmapheresis, fluid therapy, Neurology. Diseases of the nervous system, RC346-429, Medicine

File Description: electronic resource

Relation: http://psypharma.ru/ru/zlokachestvennyy-neyrolepticheskiy-sindrom-zns-u-bolnoy-bipolyarnym-affektivnym-rasstroystvom-na; https://doaj.org/toc/2306-4137

Access URL: https://doaj.org/article/4a1265e03a624ea29fdf09e7677e01a5

View record in DOAJ

13

Academic Journal

MINIMIZING ECT COGNITIVE SIDE EFFECTS: CURRENT CLINICAL REALITY AND FUTURE PERSPECTIVES (A REVIEW OF THE LITERATURE WITH AUTHOR COMMENTS AND RECOMMENDATIONS) PART II (PRACTICAL)

Authors: Yuriy Vitalevich Bykov, Roman Aleksandrovich Bekker

Source: В мире научных открытий, Vol 0, Iss 12, Pp 200-272 (2017)

Subject Terms: электросудорожная терапия, когнитивные нарушения, ретроградная амнезия, антероградная амнезия, депрессивные нарушения, патофизиология когнитивных нарушений, Agriculture, Science

File Description: electronic resource

Relation: http://journal-s.org/index.php/vmno/article/view/9613; https://doaj.org/toc/2072-0831; https://doaj.org/toc/2307-9428

Access URL: https://doaj.org/article/741316a2dced451ca4ea2972d3fdbde5

View record in DOAJ Full Text Finder

14

Academic Journal

MINIMIZING ECT COGNITIVE SIDE EFFECTS: CURRENT CLINICAL REALITY AND FUTURE PERSPECTIVES (A REVIEW OF THE LITERATURE WITH AUTHOR COMMENTS AND RECOMMENDATIONS) PART I (THEORETICAL)

Authors: Yuriy Vitalevich Bykov, Roman Aleksandrovich Bekker

Source: В мире научных открытий, Vol 0, Iss 10, Pp 54-92 (2016)

Subject Terms: электросудорожная терапия, когнитивные нарушения, ретроградная амнезия, антероградная амнезия, депрессивные нарушения, патофизиология когнитивных нарушений, Agriculture, Science

File Description: electronic resource

Relation: http://journal-s.org/index.php/vmno/article/view/9448; https://doaj.org/toc/2072-0831; https://doaj.org/toc/2307-9428

Access URL: https://doaj.org/article/da8887b3bcda4a8aa986076e745516f0

View record in DOAJ Full Text Finder

15

Academic Journal

Злокачественный нейролептический синдром: диагностика и терапия

Authors: Малин, Д.И.

Source: Современная терапия психических расстройств, Vol 2016, Iss 2 (37), Pp 2-7 (2016)

Subject Terms: злокачественный нейролептический синдром, фебрильная кататония, экстрапирамидные симптомы, электросудорожная терапия, поддерживающая терапия, фармакологическое лечение, neuroleptic malignant syndrome, febrile catatonia, extrapyramidal symptoms, electroconvulsive therapy, supportive therapy, pharmacological treatment, Neurology. Diseases of the nervous system, RC346-429, Medicine

File Description: electronic resource

Relation: http://www.psypharma.ru/ru/zlokachestvennyy-neyrolepticheskiy-sindrom-diagnostika-i-terapiya; https://doaj.org/toc/2306-4137

Access URL: https://doaj.org/article/22d3e5fc73d941e8a802c4b6a1171ca3

View record in DOAJ

16

Academic Journal

The method of combination of electroconvulsive therapy and postictally hypnotherapy in the treatment of patients with therapeutically resistant depression = Комбинация электросудорожной терапии и постиктальной гипнотерапии в лечении пациентов с терапевтически резистентной депрессией

Authors: V. V. Chugunov, V. O. Kurilo, N. V. Danilevska, A. Z. Grigoryan

Source: Journal of Education, Health and Sport, Vol 6, Iss 6, Pp 51-58 (2016)

Subject Terms: electroconvulsive therapy, depression, postictally hypnotherapy, электросудорожная терапия, депрессия, постиктальное внушение., Education, Sports, GV557-1198.995, Medicine

File Description: electronic resource

Relation: http://www.ojs.ukw.edu.pl/index.php/johs/article/view/3545; https://doaj.org/toc/2391-8306

Access URL: https://doaj.org/article/32f57988af9842c6b7dfb134a4301e30

View record in DOAJ Full Text Finder

17

Academic Journal

Периоперационное ведение пациентов с депрессией

Authors: Виктория Владимировна Мясникова, А. Е. Муронов

Source: Вестник интенсивной терапии, Iss 1 (2018)

Subject Terms: депрессия, периоперационное ведение, антидепрессанты, электросудорожная терапия, Medical emergencies. Critical care. Intensive care. First aid, RC86-88.9

File Description: electronic resource

Relation: https://intensive-care.ru/index.php/acc/article/view/114; https://doaj.org/toc/1726-9806; https://doaj.org/toc/1818-474X

Access URL: https://doaj.org/article/905517fb08c64327bbcaacddd094276a

View record in DOAJ

18

Academic Journal

Применение транскраниальной магнитной стимуляции и электросудорожной терапии при терапевтически резистентных депрессиях

Authors: Ильин, С.А., Мосолов, С.Н., Цукарзи, Э.Э.

Source: Современная терапия психических расстройств, Vol 2015, Iss 4 (35), Pp 25-32 (2015)

Subject Terms: transcranial magnetic stimulation (tms), electroconvulsive therapy (ect), therapyqresistant depressions, remissions, follow-up asessment, транскраниальная магнитная стимуляция (тмс), электросудорожная терапия (эст), терапевтически резистентные депрессии, ремиссии, катамнестическая оценка, Neurology. Diseases of the nervous system, RC346-429, Medicine

File Description: electronic resource

Relation: http://www.psypharma.ru/primenenie-transkranialnoy-magnitnoy-stimulyacii-i-elektrosudorozhnoy-terapii-pri-terapevticheski; https://doaj.org/toc/2306-4137

Access URL: https://doaj.org/article/4e3340b01293443d8302488771b67761

View record in DOAJ

19

Academic Journal

Ect And Psychotherapy Combination In Treatment Of Affective Disorders In Structure Of Addictions. Analisis Of Efficaсy ; Анализ эффективности терапии аффективных нарушений в структуре аддиктивной патологии методом эст в сочетании с психотерапией ; Аналіз ефективності терапії афективних порушень у структурі адиктивної патології методом ест у поєднанні з психотерапією

Authors: Григорян, А. З.

Source: Psychiatry, Neurology and Medical Psychology; Том 2, № 2 (4) (2015); 122–126 ; Психиатрия, неврология и медицинская психология; Том 2, № 2 (4) (2015); 122–126 ; Психіатрія, неврологія та медична психологія; Том 2, № 2 (4) (2015); 122–126 ; 2411-166X ; 2312-5675

Subject Terms: Electroconvulsive Therapy, Affective Disorders, Drug Addiction, Positive and Negative Syndrome Scale, электросудорожная терапия, аффективные расстройства, наркомания, шкала оценки позитивной и негативной симптоматики, електросудомна терапія, афективні розлади, наркоманія, шкала оцінки позитивних та негативних синдромів